SC1-BHC-27-2018
SC1-BHC-27-2018
8 projects · €49,927,504 total EU contribution (project-level) · 87 participating organizations · 19 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€49,927,504
Countries active
Participant organizations by country (headquarters in CORDIS).
- France (17)
- Germany (13)
- UK (9)
- SE (7)
- Netherlands (6)
- BE (4)
- Spain (4)
- Italy (4)
- AU (3)
- CZ (3)
- DK (3)
- IE (3)
- US (3)
- EL (2)
- FI (2)
- CH (1)
- EE (1)
- JP (1)
- NO (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- BRUNEL UNIVERSITY LONDON3 projects · UK
- CNRS3 projects · FR
- INSERM3 projects · FR
- KI3 projects · SE
- MNHN3 projects · FR
- STICHTING VU3 projects · NL
- UU3 projects · NL
- ANSES2 projects · FR
- BFR2 projects · DE
- TECHNICAL UNIVERSITY OF DENMARK DTU2 projects · DK
- INRAE2 projects · FR
- KU2 projects · SE
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Breaking down the wall between human health and environmental testing of endocrine disrupters: EndocRine Guideline Optimisation ERGO · 825753 | H2020 | €5,992,437 | €468,040 | Details |
Metabolic effects of Endocrine Disrupting Chemicals: novel testing METhods and adverse outcome pathways EDCMET · 825762 | H2020 | €5,980,409 | €280,004 | Details |
An integrative strategy of testing systems for identification of EDs related to metabolic disorders OBERON · 825712 | H2020 | €5,978,763 | €215,250 | Details |
Female Reproductive toxicity of EDCs: a human evidence-based screening and Identification Approach FREIA · 825100 | H2020 | €6,104,476 | €201,740 | Details |
Beating Goliath: Generation Of NoveL, Integrated and Internationally Harmonised Approaches for Testing Metabolism Disrupting Compounds GOLIATH · 825489 | H2020 | €6,761,834 | €134,250 | Details |
A multistage model of thyroid gland function for screening endocrine-disrupting chemicals in a biologically sex-specific manner SCREENED · 825745 | H2020 | €5,655,089 | €416,404 | Details |
Assays for the identification of Thyroid Hormone axis-disrupting chemicals: Elaborating Novel Assessment strategies ATHENA · 825161 | H2020 | €6,565,464 | €50,538 | Details |
Novel Testing Strategies for Endocrine Disruptors in the Context of Developmental NeuroToxicity ENDpoiNTs · 825759 | H2020 | €6,889,033 | €101,678 | Details |